Dyne Therapeutics, Inc. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated March 18, 2025, between the Company and Erick Lucera
Dyne Therapeutics, Inc.
Biotechnology
2025
Offer letter, dated as of July 23, 2024, by and between the registrant and Douglas Kerr
Dyne Therapeutics, Inc.
Biotechnology
MA
2024
Offer Letter, dated March 21, 2024, between the Company and John Cox
Dyne Therapeutics, Inc.
Biotechnology
MA
2024
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
Dyne Therapeutics, Inc.
Biotechnology
2022
Offer letter, dated as of December 17, 2020, by and between the registrant and Wildon Farwell
Dyne Therapeutics, Inc.
Biotechnology
MA
2021
Description of Securities Registered Under Section 12 of the Exchange Act
Dyne Therapeutics, Inc.
Biotechnology
2021
Offer letter, dated as of July 24, 2020, by and between the registrant and Susanna High
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of November 8, 2019, by and between the registrant and Richard Scalzo
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of December 12, 2019, by and between the registrant and Oxana Beskrovnaya
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of December 21, 2018, by and between the registrant and Jonathan McNeill
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of March 21, 2018, by and between the registrant and Romesh Subramanian
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of September 19, 2019, by and between the registrant and Joshua Brumm
Dyne Therapeutics, Inc.
Biotechnology
MA
2020